News RSS Bioethics News.


New clues to why a French drug trial went horribly wrong

External Link - Source: Science

Although Bial and Biotrial have been heavily criticized for the study, French authorities have concluded that the companies did not violate clinical trial regulations. In the wake of the case, the European Medicines Agency is developing stricter rules for “first-in-human” studies.